Novasep and Nilsan Nishotech to Install Continuous Chromatography System at Laurus Labs
Novasep, a supplier of life-sciences manufacturing solutions, and its partner Nilsan Nishotech Systems, a process engineering specialist in India, announced the commissioning of a continuous chromatography Varicol system at Laurus Labs, an API manufacturer based in India.
Novasep, a supplier of life-sciences manufacturing solutions, and its partner Nilsan Nishotech Systems, a process engineering specialist in India, announced the commissioning of a continuous chromatography Varicol system at Laurus Labs, an API manufacturer based in India.
This is the first time Laurus Labs will use a continuous chromatography system at multi-ton scale to obtain high productivity and cost-efficient chiral molecule separation.
Varicol continuous chromatography is used to separate enantiomers from racemic mixtures. A key feature is the solvent recycling unit associated with the chromatography system enabling the process to exhibit low solvent consumption (more than 99.9% solvent recovery).
According to the press release, Novasep’s Varicol is capable of achieving separation of 500 kg per day in Laurus Labs’ production of API. Prior to the installation, Novasep conducted a feasibility study at its R&D laboratory in Pompey, France, to evaluate the continuous process on a small-scale.
Source: Novasep
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
